US Stock MarketDetailed Quotes

Utah Medical Products (UTMD)

Watchlist
  • 63.340
  • -0.360-0.57%
Close May 15 16:00 ET
  • 63.340
  • 0.0000.00%
Post 16:10 ET
201.68MMarket Cap18.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Utah Medical Products (UTMD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-30.35%3.11M
-0.94%14.69M
18.39%3.48M
0.57%3.88M
4.02%2.87M
-15.39%4.46M
-33.44%14.83M
-44.92%2.94M
-24.70%3.86M
-43.78%2.76M
Net income from continuing operations
-14.37%2.6M
-18.65%11.29M
-11.58%2.57M
-26.16%2.63M
-11.73%3.05M
-23.13%3.04M
-16.60%13.87M
-32.29%2.9M
-9.45%3.56M
-17.79%3.45M
Depreciation and amortization
-4.58%688K
5.69%3.01M
4.11%760K
3.92%769K
9.38%758K
5.56%721K
-55.31%2.85M
-29.81%730K
-58.54%740K
-61.05%693K
Deferred tax
24.88%-157K
-94.97%-659K
-130.51%-18K
-430.19%-281K
6.21%-151K
-14.21%-209K
50.37%-338K
114.43%59K
63.19%-53K
-26.77%-161K
Change In working capital
-116.83%-141K
117.58%317K
110.39%86K
158.84%263K
31.87%-870K
11.88%838K
-673.82%-1.8M
-340.00%-828K
11.13%-447K
-32.74%-1.28M
-Change in receivables
-1,183.33%-130K
142.64%333K
190.53%430K
-5,522.22%-506K
578.31%397K
105.61%12K
-134.41%-781K
-446.72%-475K
-110.11%-9K
-132.55%-83K
-Change in inventory
-401.82%-830K
103.58%1.2M
135.44%186K
50.75%101K
272.35%633K
1.48%275K
187.61%587K
-69.02%79K
-79.06%67K
205.59%170K
-Change in prepaid assets
-253.85%-92K
-68.75%-54K
-23.26%-106K
-1,133.33%-93K
29.55%171K
70.11%-26K
-171.11%-32K
-430.77%-86K
-43.75%9K
700.00%132K
-Change in payables and accrued expense
57.89%911K
26.63%-1.16M
-22.54%-424K
248.05%761K
-38.44%-2.07M
-25.93%577K
16.03%-1.58M
-373.97%-346K
44.61%-514K
-44.68%-1.5M
Cash from discontinued investing activities
Operating cash flow
-30.35%3.11M
-0.94%14.69M
18.39%3.48M
0.57%3.88M
4.02%2.87M
-15.39%4.46M
-33.44%14.83M
-44.92%2.94M
-24.70%3.86M
-43.78%2.76M
Investing cash flow
Cash flow from continuing investing activities
29.35%-130K
-78.37%-371K
-1,111.11%-109K
69.66%-27K
55.65%-51K
-3,780.00%-184K
67.45%-208K
90.00%-9K
52.15%-89K
64.06%-115K
Capital expenditure reported
----
-57.87%-371K
----
----
55.65%-51K
-736.36%-184K
63.22%-235K
90.00%-9K
52.15%-89K
64.06%-115K
Net PPE purchase and sale
29.35%-130K
--0
18.55%262K
-18.55%-262K
--184K
-781.48%-184K
--27K
--221K
---221K
--0
Cash from discontinued investing activities
Investing cash flow
29.35%-130K
-78.37%-371K
-1,111.11%-109K
69.66%-27K
55.65%-51K
-3,780.00%-184K
67.45%-208K
90.00%-9K
52.15%-89K
64.06%-115K
Financing cash flow
Cash flow from continuing financing activities
73.64%-1.12M
48.24%-12.34M
74.56%-1.97M
66.63%-1.64M
37.58%-4.49M
-6.40%-4.24M
-472.34%-23.84M
-623.34%-7.75M
-375.17%-4.92M
-611.88%-7.19M
Net common stock issuance
96.03%-128K
58.16%-8.36M
85.18%-994K
83.11%-653K
45.54%-3.49M
-7.73%-3.22M
---19.97M
---6.71M
---3.87M
---6.4M
Cash dividends paid
2.75%-989K
6.50%-3.98M
5.88%-977K
6.08%-988K
7.40%-1M
6.61%-1.02M
0.51%-4.26M
3.08%-1.04M
1.77%-1.05M
-1.03%-1.08M
Proceeds from stock option exercised by employees
----
--0
--0
--0
--0
--0
233.33%390K
--0
--0
390.00%294K
Cash from discontinued financing activities
Financing cash flow
73.64%-1.12M
48.24%-12.34M
74.56%-1.97M
66.63%-1.64M
37.58%-4.49M
-6.40%-4.24M
-472.34%-23.84M
-623.34%-7.75M
-375.17%-4.92M
-611.88%-7.19M
Net cash flow
Beginning cash position
3.35%85.76M
-10.65%82.98M
-4.73%84.27M
-7.89%82.18M
-11.17%83.33M
-10.65%82.98M
23.74%92.87M
0.28%88.45M
5.44%89.22M
15.94%93.81M
Current changes in cash
4,333.33%1.86M
121.52%1.98M
128.99%1.4M
292.01%2.21M
63.33%-1.67M
-96.76%42K
-152.73%-9.22M
-215.54%-4.82M
-129.51%-1.15M
-226.79%-4.54M
Effect of exchange rate changes
-169.06%-212K
217.73%797K
114.00%92K
-131.77%-122K
1,230.43%520K
185.75%307K
-299.71%-677K
-234.63%-657K
223.87%384K
-137.10%-46K
End cash Position
4.90%87.41M
3.35%85.76M
3.35%85.76M
-4.73%84.27M
-7.89%82.18M
-11.17%83.33M
-10.65%82.98M
-10.65%82.98M
0.28%88.45M
5.44%89.22M
Free cash flow
-30.40%2.98M
-1.88%14.32M
15.03%3.37M
2.23%3.85M
6.61%2.82M
-18.54%4.28M
-32.56%14.6M
-44.14%2.93M
-23.67%3.77M
-42.37%2.65M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -30.35%3.11M-0.94%14.69M18.39%3.48M0.57%3.88M4.02%2.87M-15.39%4.46M-33.44%14.83M-44.92%2.94M-24.70%3.86M-43.78%2.76M
Net income from continuing operations -14.37%2.6M-18.65%11.29M-11.58%2.57M-26.16%2.63M-11.73%3.05M-23.13%3.04M-16.60%13.87M-32.29%2.9M-9.45%3.56M-17.79%3.45M
Depreciation and amortization -4.58%688K5.69%3.01M4.11%760K3.92%769K9.38%758K5.56%721K-55.31%2.85M-29.81%730K-58.54%740K-61.05%693K
Deferred tax 24.88%-157K-94.97%-659K-130.51%-18K-430.19%-281K6.21%-151K-14.21%-209K50.37%-338K114.43%59K63.19%-53K-26.77%-161K
Change In working capital -116.83%-141K117.58%317K110.39%86K158.84%263K31.87%-870K11.88%838K-673.82%-1.8M-340.00%-828K11.13%-447K-32.74%-1.28M
-Change in receivables -1,183.33%-130K142.64%333K190.53%430K-5,522.22%-506K578.31%397K105.61%12K-134.41%-781K-446.72%-475K-110.11%-9K-132.55%-83K
-Change in inventory -401.82%-830K103.58%1.2M135.44%186K50.75%101K272.35%633K1.48%275K187.61%587K-69.02%79K-79.06%67K205.59%170K
-Change in prepaid assets -253.85%-92K-68.75%-54K-23.26%-106K-1,133.33%-93K29.55%171K70.11%-26K-171.11%-32K-430.77%-86K-43.75%9K700.00%132K
-Change in payables and accrued expense 57.89%911K26.63%-1.16M-22.54%-424K248.05%761K-38.44%-2.07M-25.93%577K16.03%-1.58M-373.97%-346K44.61%-514K-44.68%-1.5M
Cash from discontinued investing activities
Operating cash flow -30.35%3.11M-0.94%14.69M18.39%3.48M0.57%3.88M4.02%2.87M-15.39%4.46M-33.44%14.83M-44.92%2.94M-24.70%3.86M-43.78%2.76M
Investing cash flow
Cash flow from continuing investing activities 29.35%-130K-78.37%-371K-1,111.11%-109K69.66%-27K55.65%-51K-3,780.00%-184K67.45%-208K90.00%-9K52.15%-89K64.06%-115K
Capital expenditure reported -----57.87%-371K--------55.65%-51K-736.36%-184K63.22%-235K90.00%-9K52.15%-89K64.06%-115K
Net PPE purchase and sale 29.35%-130K--018.55%262K-18.55%-262K--184K-781.48%-184K--27K--221K---221K--0
Cash from discontinued investing activities
Investing cash flow 29.35%-130K-78.37%-371K-1,111.11%-109K69.66%-27K55.65%-51K-3,780.00%-184K67.45%-208K90.00%-9K52.15%-89K64.06%-115K
Financing cash flow
Cash flow from continuing financing activities 73.64%-1.12M48.24%-12.34M74.56%-1.97M66.63%-1.64M37.58%-4.49M-6.40%-4.24M-472.34%-23.84M-623.34%-7.75M-375.17%-4.92M-611.88%-7.19M
Net common stock issuance 96.03%-128K58.16%-8.36M85.18%-994K83.11%-653K45.54%-3.49M-7.73%-3.22M---19.97M---6.71M---3.87M---6.4M
Cash dividends paid 2.75%-989K6.50%-3.98M5.88%-977K6.08%-988K7.40%-1M6.61%-1.02M0.51%-4.26M3.08%-1.04M1.77%-1.05M-1.03%-1.08M
Proceeds from stock option exercised by employees ------0--0--0--0--0233.33%390K--0--0390.00%294K
Cash from discontinued financing activities
Financing cash flow 73.64%-1.12M48.24%-12.34M74.56%-1.97M66.63%-1.64M37.58%-4.49M-6.40%-4.24M-472.34%-23.84M-623.34%-7.75M-375.17%-4.92M-611.88%-7.19M
Net cash flow
Beginning cash position 3.35%85.76M-10.65%82.98M-4.73%84.27M-7.89%82.18M-11.17%83.33M-10.65%82.98M23.74%92.87M0.28%88.45M5.44%89.22M15.94%93.81M
Current changes in cash 4,333.33%1.86M121.52%1.98M128.99%1.4M292.01%2.21M63.33%-1.67M-96.76%42K-152.73%-9.22M-215.54%-4.82M-129.51%-1.15M-226.79%-4.54M
Effect of exchange rate changes -169.06%-212K217.73%797K114.00%92K-131.77%-122K1,230.43%520K185.75%307K-299.71%-677K-234.63%-657K223.87%384K-137.10%-46K
End cash Position 4.90%87.41M3.35%85.76M3.35%85.76M-4.73%84.27M-7.89%82.18M-11.17%83.33M-10.65%82.98M-10.65%82.98M0.28%88.45M5.44%89.22M
Free cash flow -30.40%2.98M-1.88%14.32M15.03%3.37M2.23%3.85M6.61%2.82M-18.54%4.28M-32.56%14.6M-44.14%2.93M-23.67%3.77M-42.37%2.65M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -